It indicated that neither the circulating level of IGF-1 nor that of IGFBP-3 could act as long-term(the follow-up period were all more than five years and some even more than twenty years in the prospective studies we included in this meta-analysis)predictor of lung cancer. The gene discussed is IGF1; the disease is lung carcinoma.